Denali Therapeutics
Denali Therapeutics Inc. is a biotechnology company that focuses on the discovery and development of therapies for patients who are suffering from neurodegenerative diseases, including Parkinson’s disease, Alzheimer’s disease, ALS, and more.
AngelList URL
CAGE Code
81T85
0
CEO
CIK Number
Legal Name
Denali Therapeutics Inc.
Company Operating Status
Active
Contact Page URL
Country
Crunchbase URL
DUNS Number
079861913
0
Founded Date
May 14, 2015
Full Address
161 Oyster Point Blvd. South San Francisco, CA 94080, USA
0
IRS Number
463,872,213
0
Latest Funding Round Date
August 25, 2016
Latest Funding Type
LinkedIn URL
Number of Employees
395
0
Number of Employees (Ranges)
201 – 500
0
Patents Assigned (Count)
21
Pitchbook URL
Place of Incorporation
SIC Code
2,836
0
Exchange
Stock Symbol
DNLI
0
Ticker Symbol
DNLI
Total Funding Amount (USD)
130,000,000
Official Website
Wellfound ID
Find more companies like Denali Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.